After two decades of steady decline, the number of tuberculosis (TB) cases reported in the U.S. rose to 9,563 in 2015, serving as a reminder of the importance of continued efforts to eliminate this potentially fatal disease. Each day, health care professionals work diligently to treat patients with TB. To support this critical work, the Centers for Disease Control and Prevention (CDC), the American Thoracic Society (ATS), and the Infectious Diseases Society of America (ISDA) updated evidence-based guidelines for treatment of TB.
The updated guidelines strongly recommend that patients with tuberculosis and HIV infection receive Antiretroviral Therapy (ART) during TB treatment, and provide details about the recommended timing of ART initiation. Also included in the guidelines are specific recommendations regarding comprehensive case management for patients with TB.
Click here to access the Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis online.